Clinical Trials Sponsored by Plasma Services Group

Total 457 results

WiSP Wissenschaftlicher Service Pharma GmbH
ClinAssess GmbH

Unknown

Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer (PROVE)

Ovarian Cancer

Germany
Hong Kong Prospect Group Co. Limited
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

A Study to Evaluate the Impact of a Nutritional Product on Cognition in Healthy Teenagers

Healthy

United States
Herantis Pharma Plc.
Clinical Research Services Turku - CRST Oy

Completed

Single Ascending Doses of HER-096 in Healthy Subjects

Parkinson Disease

Finland
Nordic Pharma, USA
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

A Marketing-oriented Study to Evaluate the Comparative Bioavailability of Omega-3 Fatty Acids From Four Different Natural Health Products

Comparative Bioavailability

Canada
HEM Pharma Inc.
Premier Research Group plc

Not yet recruiting

HEM1036 Phase 2 Study in Low Anterior Resection Syndrome

LARS - Low Anterior Resection Syndrome
Tris Pharma, Inc.
Premier Research Group plc

Completed

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

ADHD

United States
Polish Lymphoma Research Group
Roche Pharma AG

Terminated

Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse (OPERA-PLRG10)

Mantle Cell Lymphoma

Poland
Galderma R&D
Pharma Consulting Group AB

Withdrawn

Macrolane Prospective Survey

Females Recently Treated With Macrolane VRF in the Breasts

Sweden
Finnish Lung Cancer Group
Roche Pharma AG

Completed

Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC

Non-small Cell Lung Cancer

Finland
Nordic Pharma, USA
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

Safety and Efficacy of a Natural Health Product in Reducing Cholesterol and Triglyceride Levels.

Triglycerides | LDL Cholesterol

Canada
ITEL Telecomunicazioni Srl
Advice Pharma Group srl

Not yet recruiting

Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7 (MIP7)

Prostate Cancer | Radiotherapy | Prostatectomy | 18F- Fluorocholine | PSMA PET | Tumor of Prostate
West German Study Group
Roche Pharma AG

Active, not recruiting

A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol. (ADAPT; T-DM1)

Breast Cancer

Germany
Galderma R&D
Pharma Consulting Group AB

Completed

Treatment of Pectus Excavatum Deformity Using Macrolane Filler

Pectus Excavatum Deformity

France, Sweden
PepTonic Medical AB
Pharma Consulting Group AB

Completed

Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women (OXYPEP002)

Vaginal Atrophy

Sweden
Aboca Spa Societa' Agricola
GB Pharma Group

Completed

Effectiveness & Safety of Neofitoroid® in Hemorrhoidal Disease

Hemorrhoids

Italy
Dutch Colorectal Cancer Group
Nordic Pharma SAS

Completed

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients. (SALTO)

Colorectal Cancer | Metastases

Netherlands
Mediforum Ltd., Co.
LSK Global Pharma Services Co. Ltd.

Recruiting

A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease (PM012-2b)

Mild Alzheimer Disease

Korea, Republic of
Nutrin GmbH
Mittal Global Clinical Trial Services; Galaxa Pharma

Completed

NGA-01 Gel for the Treatment of Osteoarthritis With Joint Pain

Arthritis Osteoarthritis

India
Nordic Pharma, USA
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

A Comparator Trial on the Relative Efficacy of Two Triglyceride Forms of Fish Oil

Healthy Volunteers

Canada
Nordic Pharma, USA
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Withdrawn

Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction (PrOteCT)

Mixed Hyperlipoproteinemia
NCIC Clinical Trials Group
Sumitomo Pharma Oncology, Inc.

Completed

BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma

Colorectal Carcinoma

Canada, Australia, Japan
West German Study Group
Roche Pharma AG

Recruiting

A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol (ADAPT)

Breast Cancer

Germany
IRCCS San Raffaele
Advice Pharma Group srl

Completed

Ischemia in Patients With Non-obstructive Disease (INOCA) in Italy INOCA IT Multicenter Registry" (INOCAIT)

Cardiac Ischemia

Italy
Environment and Health Group, Inc.
Prisma Health

Completed

mHealth for ART Adherence by HIV+ African Americans

HIV-1-infection

United States
Istituto Clinico Humanitas
CD Pharma Group S.r.l.

Unknown

Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated Cirrhosis (GECOM)

Hepatitis C | Compensated Cirrhosis
Borstkanker Onderzoek Groep
Roche Pharma AG; Teva Pharma

Completed

8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer (Stop&Go)

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Netherlands
WiSP Wissenschaftlicher Service Pharma GmbH
Bristol-Myers Squibb; Roche Pharma AG

Completed

Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer

Metastatic Breast Cancer

Germany
Institut fuer Frauengesundheit
GlaxoSmithKline; Schantl Pharma Service, Germany

Unknown

Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma (AGO-Zervix-1)

Recurrent, Persistent or Metastasized Cervical Cancer

Germany
Advanz Pharma
AMS Advanced Medical Services GmbH; APCER Life Sciences

Completed

Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases (RETRACE)

Hepatic Insufficiency | Renal Insufficiency | Immunosuppression

Spain, France, Germany, Italy
RenJi Hospital
Nitto Denko Corporation; Giant Med-Pharma Services Inc.

Unknown

Lidocaine Patches for Attenuating the Pain of Venipuncture Intravenous Cannulation

We Focus on the Pain of Venipuncture and Intravenous Cannulation

China
sigma-tau i.f.r. S.p.A.
CPR Pharma Services Pty Ltd, Australia

Completed

Food Interaction Study on the Pharmacokinetics of Eurartesim™ (DHA and PQP)in Healthy Male Adult Volunteers

Malaria, Falciparum

Australia
Luye Pharma Group Ltd.
Alliance for Clinical Trials in Oncology; Evolution Research Group

Completed

Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients

Schizophrenia Patients

United States
sigma-tau i.f.r. S.p.A.
CPR Pharma Services Pty Ltd, Australia

Completed

A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurartesim™

Malaria, Falciparum

Australia
Axcan Pharma
AAIPharma; Mayo Clinical Services; City Hospital Laboratory Birmingham

Completed

An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)

Exocrine Pancreatic Insufficiency

United States
SOLTI Breast Cancer Research Group
Roche Pharma AG

Recruiting

Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer (ATREZZO)

Breast Cancer

Spain
Ascentage Pharma Group Inc.
Merck Sharp & Dohme LLC

Recruiting

A Study of APG-115 in Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Melanoma | P53 Mutation | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Malignant Peripheral Nerve Sheath Tumors | MPNST | Unresectable or Metastatic Melanoma or Advanced Solid Tumors | MDM2 Gene Mutation

United States, Australia
German Breast Group
Roche Pharma AG; Celgene Corporation

Completed

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) (GeparSepto)

Inflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IV

Germany
West German Study Group
Sanofi; Roche Pharma AG

Terminated

Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)

Breast Cancer

Germany
Teikoku Pharma USA, Inc.
Premier Research Group plc

Completed

Dexmedetomidine Transdermal System (DMTS) for Post-Operative Analgesia Following Bunionectomy (DMTS)

Pain, Postoperative

Australia
Radboud University Medical Center
European Pharma Group (EPG)

Completed

Pharmacology of Insulin Injected With Jet-injection in Diabetes

Diabetes Mellitus

Netherlands
M.D. Anderson Cancer Center
Ascentage Pharma Group Inc.

Not yet recruiting

A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia

Advanced Chronic Myeloid Leukemia | Philadelphia Chromosome-Positive Acute Myeloid Leukemia

United States
BMG Pharma
Opera CRO, a TIGERMED Group Company

Completed

Evaluation of Safety and Performance of Ialuxid Gel in Treatment of Acne Vulgaris, and Folliculitis

Acne Vulgaris | Folliculitis

Romania
Latin American Cooperative Oncology Group
Astellas Pharma Inc

Terminated

Retrospective Analysis of 68Ga-PSMA-PET in Patients With Prostate Cancer: Experience From Brazil (PET-PSMA)

Prostate Cancer

Brazil
SunWave Pharma
Opera CRO, a TIGERMED Group Company

Unknown

Study to Assess the Efficacy and Safety of Endolex Forte VErsus Diosmin and Hesperidin in Reducing VeNous Insufficiency (EVELINE)

Chronic Venous Insufficiency
Viscogel AB
Karolinska Institutet; Pharma Consulting Group AB

Completed

Single-center Study Evaluating the Safety and Efficacy of Viscogel® as Adjuvant in Act-HIB® Vaccine (VSG-2011-101)

Healthy

Sweden
Galician Research Group on Digestive Tumors
LEO Pharma

Recruiting

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer (PROTINCOL)

Thromboembolism | Colorectal Cancer Metastatic

Spain
SOLTI Breast Cancer Research Group
Roche Pharma AG

Recruiting

Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients (IPATHER)

Metastatic Breast Cancer

Spain
Spanish Oncology Genito-Urinary Group
Roche Pharma AG

Completed

Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma (AUREA)

Locally Advanced or Metastatic Urothelial Carcinoma

Spain
GERCOR - Multidisciplinary Oncology Cooperative...
Roche Pharma AG

Active, not recruiting

A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma (SCARCE)

Anal Cancer

France
Latin American Cooperative Oncology Group
Roche Pharma AG

Completed

Molecular Characterization of Penile Cancers in Developing Countries

Penile Squamous Cell Carcinoma

Brazil

Clinical Trials Sponsored by Plasma Services Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations